Yu Tanaka

SEA0400, a Novel and Selective Inhibitor of the Na+-Ca2+ Exchanger, Attenuates Reperfusion Injury in the in Vitro and in Vivo Cerebral Ischemic Models

Naohisa Arakawa, Kazuhiro Takuma, Yoko Kishida et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 345 citations

Medicine, Neuroscience, Pharmacology +13

Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia–reperfusion injuries

Kenzo Takahashi, Teisuke Takahashi, Taizo Suzuki et al. · European Journal of Pharmacology · 2002 · 109 citations

Medicine, Cardiology, Pharmacology +10

Beneficial Effects of a New 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, TS-011 [N-(3-Chloro-4-morpholin-4-yl) Phenyl-N′-hydroxyimido Formamide], on Hemorrhagic and Ischemic Stroke

Noriyuki Miyata, Takayuki Seki, Yu Tanaka et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 99 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Effect of a New Inhibitor of the Synthesis of 20-HETE on Cerebral Ischemia Reperfusion Injury

Tomohiro Omura, Yu Tanaka, Noriyuki Miyata et al. · Stroke · 2006 · 71 citations

Medicine, Neuroscience, Pharmacology +16

Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats

Yu Tanaka, Tomohiro Omura, Misako Fukasawa et al. · Neuroscience Research · 2007 · 46 citations

Medicine, Neuroscience, Pharmacology +16